Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings.
However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
The stocks featured in this article have all approached their 52-week highs.
When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.
The stocks featured in this article have all approached their 52-week highs.
When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.
Wall Street has issued downbeat forecasts for the stocks in this article.
These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains.
This unpredictability can shake out even the most experienced investors.
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns.
Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
The stocks featured in this article are seeing some big returns.
Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro developments. As such, investors are taking notice and bidding up shares.
Unprofitable companies face headwinds as they struggle to keep operating expenses under control.
Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on.
But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks.
But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead.
They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
Since April 2025, Avantor has been in a holding pattern, posting a small return of 2.3% while floating around $15.30. The stock also fell short of the S&P 500’s 30.6% gain during that period.
U.S. Physical Therapy has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 35.2% to $89.62 per share while the index has gained 30.6%.
Over the past six months, Dole’s stock price fell to $13.19. Shareholders have lost 5.7% of their capital, which is disappointing considering the S&P 500 has climbed by 30.6%. This may have investors wondering how to approach the situation.
IAC has been treading water for the past six months, holding steady at $32.86. The stock also fell short of the S&P 500’s 30.6% gain during that period.
Even though Builders FirstSource (currently trading at $122.51 per share) has gained 7.4% over the last six months, it has lagged the S&P 500’s 30.6% return during that period. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Lumen has been on fire lately. In the past six months alone, the company’s stock price has rocketed 133%, reaching $7.15 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Over the past six months, GoodRx’s stock price fell to $3.94. Shareholders have lost 9.8% of their capital, which is disappointing considering the S&P 500 has climbed by 30.6%. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Bloom Energy has been on fire lately. In the past six months alone, the company’s stock price has rocketed 571%, reaching $109.97 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
TransDigm has been treading water for the past six months, holding steady at $1,302. The stock also fell short of the S&P 500’s 30.6% gain during that period.
The past six months have been a windfall for Flex’s shareholders. The company’s stock price has jumped 107%, hitting $63.25 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Although Zillow (currently trading at $71.68 per share) has gained 20.6% over the last six months, it has trailed the S&P 500’s 30.6% return during that period. This might have investors contemplating their next move.
P10 currently trades at $10.70 per share and has shown little upside over the past six months, posting a middling return of 2.9%. The stock also fell short of the S&P 500’s 30.6% gain during that period.
What a fantastic six months it’s been for Vimeo. Shares of the company have skyrocketed 60%, hitting $7.75. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
What a time it’s been for Diebold Nixdorf. In the past six months alone, the company’s stock price has increased by a massive 41.4%, reaching $57.41 per share. This run-up might have investors contemplating their next move.
While the S&P 500 is up 30.6% since April 2025, Walker & Dunlop (currently trading at $82.70 per share) has lagged behind, posting a return of 14.8%. This may have investors wondering how to approach the situation.
As U.S.-China trade tensions continue to escalate amid President Donald Trump's threat to add another 100% tariff on imports from the nation starting Nov. 1, Chinese President Xi Jinping is facing a rare challenge at home, according to political scientist Gordon Chang.
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the diversified banks industry, including U.S. Bancorp (NYSE:USB) and its peers.
Let’s dig into the relative performance of FuelCell Energy (NASDAQ:FCEL) and its peers as we unravel the now-completed Q2 renewable energy earnings season.
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Stitch Fix (NASDAQ:SFIX) and its peers.
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the digital media & content platforms industry, including Stride (NYSE:LRN) and its peers.
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the broadcasting industry, including FOX (NASDAQ:FOXA) and its peers.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare technology for providers stocks fared in Q2, starting with Privia Health (NASDAQ:PRVA).
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Live Nation (NYSE:LYV) and the best and worst performers in the leisure facilities industry.
Let’s dig into the relative performance of EchoStar (NASDAQ:SATS) and its peers as we unravel the now-completed Q2 traditional media & publishing earnings season.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at professional tools and equipment stocks, starting with Fortive (NYSE:FTV).
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at La-Z-Boy (NYSE:LZB) and its peers.
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the immuno-oncology industry, including Natera (NASDAQ:NTRA) and its peers.
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the engineering and design services industry, including MasTec (NYSE:MTZ) and its peers.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at medical devices & supplies - specialty stocks, starting with Haemonetics (NYSE:HAE).
Looking back on perishable food stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Calavo (NASDAQ:CVGW) and its peers.
Apple shares hit a record high after Counterpoint Research data showed iPhone 17 sales jumped 14% year-over-year, prompting analyst Gene Munster to predict over 8% iPhone growth through 2026 amid strong demand, bullish upgrades, and Apple's renewed investment push in China.
